- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lower Resp Tract Infection in Japan
Total 346 results
-
AnGes, Inc.Japan Agency for Medical Research and DevelopmentCompletedCOVID-19 Lower Respiratory InfectionJapan
-
Showa UniversityCompletedColonoscopy | Lower Gastrointestinal TractJapan
-
BayerCompleted
-
AblynxTerminatedRespiratory Syncytial Virus Lower Respiratory Tract InfectionJapan
-
Gifu Prefecture Medical AssociationSanofi Pasteur S.A.Completed
-
Taiko Pharmaceutical Co., Ltd.UnknownRespiratory InfectionJapan
-
University of ShizuokaUnknownInfluenza InfectionJapan
-
Rohto Pharmaceutical Co., Ltd.CompletedSARS-CoV-2 Infection( COVID-19 )Japan
-
University of ShizuokaHamamatsu University; Seirei Hamamatsu General HospitalCompleted
-
Masahiro MorikawaWhite Cross Nursing HomeCompletedInfluenza InfectionJapan
-
Janssen R&D IrelandCompletedRespiratory Syncytial VirusJapan
-
Ferring PharmaceuticalsCompleted
-
Ferring PharmaceuticalsCompleted
-
Ferring PharmaceuticalsCompleted
-
PfizerCompletedSARS-CoV-2 InfectionJapan
-
Meiji Seika Pharma Co., Ltd.RecruitingAcute Pyelonephritis | Complicated Intra-abdominal Infection | Complicated Urinary Tract Infection | Ventilator-associated Bacterial Pneumonia | Hospital-acquired Bacterial PneumoniaJapan
-
University of ShizuokaWhite Cross Nursing Home; Seirei Hamamatsu General Hospital; Shizuoka General...Completed
-
GlaxoSmithKlineCompletedInfections, PapillomavirusJapan
-
SanofiCompletedBenign Prostatic HyperplasiaJapan
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveJapan
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedNocturia Due to Nocturnal PolyuriaJapan
-
Ferring PharmaceuticalsCompleted
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionJapan
-
Ono Pharmaceutical Co. LtdKyorin Pharmaceutical Co.,LtdCompletedOveractive BladderJapan
-
PfizerRecruitingLower Respiratory Tract IllnessUnited States, Argentina, Canada, Finland, Japan, Netherlands, South Africa
-
Rohto Pharmaceutical Co., Ltd.CompletedSevere Acute Respiratory Syndrome Coronavirus 2Japan
-
Ferring PharmaceuticalsCompleted
-
Janssen Research & Development, LLCCompleted
-
AstraZenecaTerminatedPrevention of Infectious Disease Caused by SARS-CoV-2Japan
-
Astellas Pharma IncCompleted
-
GlaxoSmithKlineRecruiting
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveJapan
-
International Medical Center of JapanMinistry of Health, Labour and Welfare, JapanCompleted
-
Astellas Pharma IncCompletedOveractive BladderJapan
-
TakedaCompletedInfluenza InfectionJapan
-
Taiho Pharmaceutical Co., Ltd.CompletedStress Urinary IncontinenceJapan
-
Taiho Pharmaceutical Co., Ltd.CompletedStress Urinary IncontinenceJapan
-
MedicagoMitsubishi Tanabe Pharma CorporationTerminated
-
Taiho Pharmaceutical Co., Ltd.CompletedOveractive Bladder | Detrusor UnderactivityJapan
-
Merck Sharp & Dohme LLCCompletedHuman Immunodeficiency Virus (HIV) InfectionJapan
-
GlaxoSmithKlineCompleted
-
Translational Research Center for Medical Innovation...Shinshu University HospitalCompleted
-
AstraZenecaCompletedPrevention of Infectious Disease Caused by SARS-CoV-2Japan
-
GlaxoSmithKlineCompletedInfluenza, HumanJapan
-
PfizerCompleted
-
AnGes, Inc.Japan Agency for Medical Research and DevelopmentCompleted
-
TakedaCompletedPrevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)Japan